Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-05-15
1988-05-31
Rosen, Sam
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
047481811
ABSTRACT:
Hypertension is treated by chronic administration of nicotine or pharmaceutically acceptable salt of nicotine. More specifically, essential hypertension is treated in primates using effective dosages of nicotine.
REFERENCES:
patent: 3870794 (1975-03-01), Hutchinson
Nicotine and Renal Hypertension in the Rat, D. G. Wenzel, A. Wattanapongsiri and D. Vedral, J. Pharmacology & Experimental Therapeutics, vol. 145, pp. 315-316 (1964).
Studies on Mode of Action of Monoamine Oxidase Inhibitors on the Experimental Hypertension of the Rat, Chika Nagata, pp. 11-20 (319-328) (1970).
Nicotine Effects in Spontaneously Hypertensive Rats, A. S. Weltman et al., Federation Proceedings 32(3) 806 Abs. (1973).
Influence of Chronic Nicotine Administration on Blood Pressure and Heart Norepinephrine Turnover, Thomas C. Westfall, European Journal of Pharmacology, vol. 10, pp. 19-24 (1970).
Effects of Chronic Administration of Nicotine on Storage and Synthesis of Noradrenaline in Rat Brain, B. Bhagat, Br. J. Pharmac. (1970), vol. 38, pp. 86-92.
Tobacco Smoke; Comparison of Chamber and Face Mask Exposure Systems in Guinea Pigs, R. E. Goldhamer, S. Carson and E. E. Vogin, Toxicology and Applied Pharmacology, vol. 14, p. 616 (1969).
Nickerson, Goodman & Gilman (eds.) The Pharm. Basis of Therapeu-Macmillan, NY 1965 pp. 727-731.
Merck Manual of Diag. & Therapy, Merck & Co. Rahway NJ 10th Ed. 1961 pp. 210-217.
Vander et al., Human Physiol., McGraw-Hill, NY, 1970 pp. 297-298.
Best & Taylor, The Physiol. Basis of Med. Practice, Williams & Wilkins, Baltimore, 5th Ed. 1950 pp. 162-166.
Porsius, Chem. Abs., vol. 87, 1977 Ab. No. 87:177791f.
Wenzel, Arch. Internat. de Pharmacody et Therap. vol. 193, 1971 pp. 23-36.
Henry et al., Amer. J. Epidemiology, vol. 90, 1969 pp. 171-200.
Iwaki et al., Nippon Yakurigaku Zasshi, vol. 63, 1967 pp. 472-486.
Porsius et al., Prog. Brain Res., vol. 47, 1977 pp. 131-135.
Goodman & Gilman (Eds) Pharm. Basis of Therap., 5th Ed. 1975 pp. 705-726.
Larson, Tobacco-Exptl. & Clinical Studies, Supplement II Williams & Wilkins, Pub. Balto. Sections 340-349.
Karvonen, The Lancet, I Mar. 1959 pp. 492-494.
Thomas Annals. Int. Med., vol. 53, Oct., 1960 pp. 697-718.
Porsius et al., Arzneim-Forsch./Drug Res., 28 (II), Sep. 1978 pp. 1628-1631.
Bisset et al., Br. J. Pharmac., vol. 54, 1975 pp. 463-474.
Harrison's Principles of Int. Med. 7th Ed. 1974, McGraw-Hill, N.Y. pp. 188-191, 1236-1246.
Tobacco-Experimental & Clinical Studies, Supp. III 1975, Williams & Wilkins, Balt., Sections 340-349.
Wenzel et al., Arch. Intnat. de Pharm. et Therapie, vol. 187, No. 2, Oct. 1970 pp. 367-376.
Bremer et al.-Chem. Abst. vol. 55 (1961) p. 777a.
Iwaki et al., Chem. Abst. vol. 69 (1968) p. 66036x.
Greene, J. Chron. Dis. vol. 36, pp. 401-413.
Carruthers, Psychological Med., vol. 6, 1976 pp. 251-256.
Frankenhaeuser, Scand. J. Psychol. vol. 11, 1970 pp. 237-245.
Roth, Annals N.Y. Acd. Sci., vol. 90, Sep. 27, 1960 Atel, pp. 308-316.
Lucchesi, Clin. Pharmacol & Therap. vol. 8, No. 6, 1967 pp. 789-796.
Roth, JAMA, vol. 125, Jul. 15, 1944 pp. 761-767.
Emley Grace S.
Hutchinson Ronald R.
Foundation for Behavioral Research
Rosen Sam
LandOfFree
Method for treating hypertension with nicotine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating hypertension with nicotine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating hypertension with nicotine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1874531